🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Haemophilia

An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A NCT07088458n/a12 sites📍 Loma Linda📍 New Brunswick📍 Many Locations Bayer · Tests: Damoctocog alfa pegol (Jivi, Bay94-9027) Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients NCT05641610Phase 1, Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: ZS801 Manual Therapy in Hemophilic Arthropathy of the Ankle NCT06816056NA1 site📍 Murcia Investigación en Hemofilia y Fisioterapia · Tests: Manual Therapy, Placebo World Bleeding Disorders Registry NCT03327779n/a1 site📍 Montreal World Federation of Hemophilia SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors NCT04647227Phase 421 sites📍 Phoenix📍 Little Rock📍 Los Angeles American Thrombosis and Hemostasis Network · Tests: coagulation factor VIIa [recombinant]-jncw Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition NCT06090201n/a1 site📍 Lille University Hospital, Lille · Tests: 3-Tesla brain MRI and a comprehensive neuropsychological assessment Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients NCT03695978n/a59 sites📍 Miami📍 New Orleans📍 St Louis Octapharma Treatment of Hemophilia A Patients With FVIII Inhibitors NCT04023019n/a2 sites📍 Atlanta📍 Mörfelden-Walldorf Emory University · Tests: Nuwiq, Octanate, Wilate, Emicizumab, Recombinant factor VIIa (rFVIIa) Identification of New Biomarkers in Haemophilic Arthropathy Through Transcriptome Analysis NCT07867821NA1 site📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Surgery Safety and Efficacy Study of NGGT003 in Hemophilia A Patients NCT06238908EARLY Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: NGGT003 Embolization in Hereditary Coagulopathies NCT05629130NA1 site📍 São Paulo University of Sao Paulo General Hospital · Tests: embolization with spherical microparticles embosphere High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) NCT07205523n/a1 site📍 Xining Yigeng Cao,MD,PhD A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B NCT07285460Phase 337 sites📍 Los Angeles📍 Los Angeles📍 Orange Sanofi · Tests: Fitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate (ATIIIC) The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients. NCT05630651NA1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: ZS801 Validity and Reliability of the Figure-of-Eight Walking and Weight-Bearing Lunge Tests in Hemophilia NCT07851922n/a1 site📍 Van Yuzuncu Yil University A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A NCT05987449Phase 1, Phase 214 sites📍 Sacramento📍 Washington D.C.📍 Indianapolis Hoffmann-La Roche · Tests: NXT007 Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery NCT05936580Phase 416 sites📍 San Antonio📍 Helsinki📍 Chambray-lès-Tours Octapharma · Tests: Nuwiq An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B NCT06008938n/a12 sites📍 Rochester📍 Vienna📍 Århus N CSL Behring · Tests: HEMGENIX, Factor IX (FIX) Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis NCT05022459n/a10 sites📍 Little Rock📍 Palo Alto📍 San Diego Wayne State University · Tests: Emicizumab, FVIII Joint Health, Balance and Quality of Life in Adults With Hemophilia A NCT07523399n/a1 site📍 Van Yuzuncu Yil University Hemlibra in Mild Hemophilia A NCT04567511Phase 41 site📍 Indianapolis Indiana Hemophilia &Thrombosis Center, Inc. · Tests: Emicizumab A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A NCT07416526Phase 336 sites📍 Aurora📍 Iowa City📍 Godoy Cruz Hoffmann-La Roche · Tests: NXT007, Human Coagulation Factor VIII Study of Surgical Practices in Hemophilia A Patients Treated With Efanesoctocog Alfa (Altuvoct®) NCT07723560n/a1 site📍 Bron Hospices Civils de Lyon · Tests: Clinical Data Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study) NCT06864975Phase 41 site📍 Beijing Runhui WU · Tests: Advate®, Advate®, Advate®, Advate®, Advate® A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) NCT06349473Phase 110 sites📍 Glendale📍 Los Angeles📍 Chicago Equilibra Bioscience LLC · Tests: SR604, Placebo ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders NCT04398628n/a76 sites📍 Phoenix📍 Little Rock📍 Los Angeles American Thrombosis and Hemostasis Network Hemophilia A Research Program NCT07414511n/a1 site📍 Seattle University of Washington Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project NCT07418827n/a25 sites📍 Saint-Denis📍 Annecy📍 Bordeaux Assistance Publique Hopitaux De Marseille · Tests: questionnaires Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy NCT06941870Phase 414 sites📍 Los Angeles📍 Indianapolis📍 Iowa City Sanofi · Tests: Efanesoctocog alfa
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy